- Encouraging intrepreneurship in the pharmaceutical industry
- The curious case of Finland and the US trade watch list
- US Capitol Capsule: Of space, genes and genius: the future of biopharma
- Cipla's scion leaves company for 'new horizons'
ANALYSIS Other Informa Analysis
- The EMA at 20: Guido Rasi looks at how the EU regulatory landscape might change over the next decade
- PROFILE: Paula Salmikangas, chair of the EMA's Advanced Therapies Committee, on handicrafts, berry-picking and the first stem cell therapy